Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma

Blood. 2015 Sep 3;126(10):1257-8. doi: 10.1182/blood-2014-12-617779.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Adult
  • Anaplastic Lymphoma Kinase
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / drug therapy*
  • Lymphoma, Large-Cell, Anaplastic / genetics
  • Male
  • Middle Aged
  • Pyrimidines / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / genetics
  • Sulfones / therapeutic use*
  • Treatment Outcome
  • Young Adult

Substances

  • Antineoplastic Agents
  • Pyrimidines
  • Sulfones
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases
  • ceritinib

Associated data

  • ClinicalTrials.gov/NCT01283516